The Healing Company Inc.
HLCO · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.11 | -0.03 | 1.10 | -0.95 |
| FCF Yield | -2.81% | -1.17% | -0.55% | 0.11% |
| EV / EBITDA | -24.50 | -31.27 | -150.48 | -72.08 |
| Quality | ||||
| ROIC | -109.67% | -425.05% | -24.63% | -41.62% |
| Gross Margin | 52.44% | -12.92% | 57.21% | 37.70% |
| Cash Conversion Ratio | 0.62 | 0.32 | 0.72 | 0.59 |
| Growth | ||||
| Revenue 3-Year CAGR | 2,288,437.81% | 2,294,404.84% | 2,060,071.54% | 1,771,363.57% |
| Free Cash Flow Growth | 10.95% | -102.75% | -852.77% | 105.83% |
| Safety | ||||
| Net Debt / EBITDA | -0.87 | -0.42 | -1.03 | 0.44 |
| Interest Coverage | -16.30 | 0.00 | -11.05 | -10.05 |
| Efficiency | ||||
| Inventory Turnover | 0.73 | 1.41 | 0.34 | 0.36 |
| Cash Conversion Cycle | -133.13 | -41.88 | -65.94 | -24.41 |